0000899243-19-012640.txt : 20190508
0000899243-19-012640.hdr.sgml : 20190508
20190508162712
ACCESSION NUMBER: 0000899243-19-012640
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190506
FILED AS OF DATE: 20190508
DATE AS OF CHANGE: 20190508
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Klompas Neil A
CENTRAL INDEX KEY: 0001761857
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38068
FILM NUMBER: 19806993
MAIL ADDRESS:
STREET 1: 1385 WEST 8TH AVENUE
STREET 2: SUITE 540
CITY: VANCOUVER
STATE: A1
ZIP: V6H3V9
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Zymeworks Inc.
CENTRAL INDEX KEY: 0001403752
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A1
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 540-1385 WEST 8TH AVENUE
CITY: Vancouver
STATE: A1
ZIP: V6H 3V9
BUSINESS PHONE: (604) 678-1388
MAIL ADDRESS:
STREET 1: 540-1385 WEST 8TH AVENUE
CITY: Vancouver
STATE: A1
ZIP: V6H 3V9
FORMER COMPANY:
FORMER CONFORMED NAME: Zymeworks Inc
DATE OF NAME CHANGE: 20070620
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-05-06
0
0001403752
Zymeworks Inc.
ZYME
0001761857
Klompas Neil A
C/O ZYMEWORKS INC.
1385 WEST 8TH AVENUE, SUITE 540
VANCOUVER
A1
V6H 3V9
BRITISH COLUMBIA, CANADA
0
1
0
0
Chief Financial Officer
Common Stock
2019-05-06
4
M
0
6704
2.66
A
7905
D
Common Stock
2019-05-06
4
S
0
6704
19.2206
D
1201
D
Common Stock
2019-05-06
4
M
0
8380
3.53
A
9581
D
Common Stock
2019-05-06
4
S
0
1604
19.2506
D
7977
D
Common Stock
700
I
Held by spouse
Stock Option (Right to Buy)
2.66
2019-05-06
4
M
0
6704
0.00
D
2008-07-01
2019-07-01
Common Shares
6704
0
D
Stock Option (Right to Buy)
3.53
2019-05-06
4
M
0
8380
0.00
D
2010-07-01
2019-06-30
Common Shares
8380
0
D
The exercise price of the stock option is CAD3.58. The U.S. dollar equivalent of the exercise price is $2.66 using the Bank of Canada exchange rate for May 6, 2019 (CAD1.00 = $0.7432).
The shares were sold in multiple transactions and the price reported is a weighted average. The sale prices ranged from $19.07 to $19.48. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The exercise price of the stock option is CAD4.75. The U.S. dollar equivalent of the exercise price is $3.53 using the Bank of Canada exchange rate for May 6, 2019 (CAD1.00 = $0.7432).
The shares were sold in multiple transactions and the price reported is a weighted average. The sale prices ranged from $19.13 to $19.365. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Stock options vest as follows: (i) 25% of underlying shares on first anniversary of grant date of July 1, 2007, and (ii) remainder of underlying shares in 36 equal monthly installments on last day of month following first anniversary of grant date.
Stock options vest as follows: (i) 25% of underlying shares on first anniversary of grant date of July 1, 2009, and (ii) remainder of underlying shares in 36 equal monthly installments on last day of month following first anniversary of grant date.
/s/ Daniel Dex, Attorney-in-Fact
2019-05-08